All the KRAS-mutant CRC cells were obviously arrested in the G1 phase when they were treated with low concentrations of ON123300, and CRC cells accumulated significantly in the G2/M phase when treated with high concentrations of ON123300 (Fig. 1d and s4). Here, KRAS is linked to colorectal carcinoma.